Fenofibrate and Polymyalgia rheumatica - a phase IV clinical study of FDA data

Summary:

Polymyalgia rheumatica is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Primary immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Polymyalgia rheumatica when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Polymyalgia rheumatica?

Polymyalgia rheumatica (pain in many muscles) is found to be associated with 381 drugs and 554 conditions by eHealthMe. Check the latest studies of Polymyalgia rheumatica.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 15 people (0.04%) have Polymyalgia rheumatica.

Could Fenofibrate cause Polymyalgia rheumatica?

Among these 15 people:

How long have people been on Fenofibrate when they have Polymyalgia rheumatica? *

What is the gender of people who have Polymyalgia rheumatica when taking Fenofibrate? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Polymyalgia rheumatica when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

Vitamin D3: 9 people, 60.00%
Calcium: 7 people, 46.67%
Carafate: 7 people, 46.67%
Cartia Xt: 7 people, 46.67%
Lovaza: 7 people, 46.67%
Lidocaine: 4 people, 26.67%
Prednisone: 3 people, 20.00%
Epinephrine: 3 people, 20.00%
Acetaminophen: 3 people, 20.00%
Diphenhydramine Hydrochloride: 2 people, 13.33%

What are other side effects people have besides Polymyalgia rheumatica? *

Rashes (redness): 8 people, 53.33%
Upper-Airway Cough Syndrome: 7 people, 46.67%
Pain In Extremity: 7 people, 46.67%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 40.00%
Urinary Tract Infection: 6 people, 40.00%
Obstruction: 6 people, 40.00%
Infusion Site Haemorrhage (bleeding from infusion site): 6 people, 40.00%
Canker Sores (painful, open sore in the mouth): 5 people, 33.33%
Poor Venous Access: 5 people, 33.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 33.33%

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 7 people, 46.67%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 33.33%
Immunodeficiency Common Variable: 3 people, 20.00%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 1 person, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
Pain: 1 person, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
Dyslipidaemia (abnormal amount of lipids): 1 person, 6.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 6.67%
Constipation: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Polymyalgia rheumatica?

- Check whether Polymyalgia rheumatica is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,457 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Polymyalgia rheumatica:

Polymyalgia rheumatica (381 drugs)

Browse all the conditions that are associated with Polymyalgia rheumatica:

Polymyalgia rheumatica (554 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.